And Speaking of Early Cancer Detection and Treatment...

in #finance7 years ago

There's another stock I have - Trovagene (TROV) - that is also involved with early cancer detection through non-invasive liquid biopsies, as well as newly acquiring a clinical-stage therapeutic that shows a lot of promise. This morning, they announced the start of a Phase 1b/2 multi-center trial with the drug candidate PCM-075 at Virginia Cancer Specialists ( https://finance.yahoo.com/news/trovagene-announces-activation-first-clinical-130000326.html ). Now, don't count on me for any good investment advice. I seem to manage to buy high and sell low - but I've held and accumulated this since about $7.00, knowing that it will break way high any time now! :) There are price targets of $6.00, $9.00 on its potential, successes and partnerships but the share price wallows at around 70 cents. I may not be a stock guru but one would think if they're in position to jump in share price soon, like LLBO/Cyrcadia (I hope!), and are selling at 70-cents/share, that's supposed to be where you enter, right?? Unlike me, who starts in the middle and rides the wave down. Just sayin'... in case you have some spare dollars to try for a big gain. I wish these investments could execute in their window of opportunity but that's your high-risk/high-reward strategy. Like gambling, never bet more than you can afford to lose!